EP2367553
COMBINATION THERAPY TO ENHANCE NK CELL MEDIATED CYTOTOXICITY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
4.12.2009EP published:
3.5.2017EP application number:
09771629.4
EPO information:
European Patent Register
Max expiry date:
3.12.2029
Title:
COMBINATION THERAPY TO ENHANCE NK CELL MEDIATED CYTOTOXICITY
Timeline
Today
4.12.2009EP application
3.5.2017EP Publication
Owner
Name:
Novo Nordisk A/SAddress:
Novo Allé, 2880, Bagsværd, DK
Inventor
Name:
FARAG, Sherif, S.Address:
CarmelIN, US
Priority
Number:
120242 PDate:
5.12.2008Country:
US
Classification
Categories:
A61K 31/4439, A61K 39/395, A61P 35/00